Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Charles Stanley And Nomura Cut Standard Chartered

Wed, 29th Oct 2014 09:41

LONDON (Alliance News) - The following UK shares received analyst recommendations Wednesday morning and late Tuesday:
----------
FTSE 100
----------
S&P CAPITAL IQ RAISES BG GROUP TO 'HOLD' ('SELL') - PRICE TARGET 1050 PENCE
----------
BARCLAYS CUTS BG GROUP PRICE TARGET TO 1300 (1350) PENCE - 'EQUAL WEIGHT'
----------
UBS RAISES ITV PRICE TARGET TO 230 (210) PENCE - 'BUY'
----------
CREDIT SUISSE CUTS PETROFAC PRICE TARGET TO 1250 (1340) PENCE
----------
UBS CUTS STANDARD CHARTERED PRICE TARGET TO 1120 (1315) PENCE - 'BUY'
----------
GOLDMAN CUTS STANDARD CHARTERED PRICE TARGET TO 1130 (1240) PENCE - 'NEUTRAL'
----------
TRADERS: NOMURA CUTS STANDARD CHARTERED TO 'NEUTRAL' ('BUY')
----------
EXANE BNP CUTS STANDARD CHARTERED PRICE TARGET TO 1000 (1260) PENCE - UNDERPERFORM
----------
HSBC CUTS STANDARD CHARTERED PRICE TARGET TO 950 (1150) PENCE - 'UNDERWEIGHT'
----------
NUMIS CUTS STANDARD CHARTERED PRICE TARGET TO 1000 (1200) PENCE - 'HOLD'
----------
CHARLES STANLEY CUTS STANDARD CHARTERED TO HOLD (ACCUMULATE) - TARGET 1150 (1400) PENCE
----------
Deutsche Bank Cuts Standard Life Price Target To 445p From 455p, Buy
----------
MORGAN STANLEY RAISES ANGLO AMERICAN PRICE TARGET TO 1500 (1440) PENCE - 'UNDERWEIGHT.'
----------
LBBW CUTS BP PRICE TARGET TO 520 (550) PENCE - 'BUY'
----------
TRADERS: BERNSTEIN RAISES ROLLS-ROYCE TO 'MARKET-PERFORM' ('UNDERPERFORM')
----------
FTSE 250
----------
CREDIT SUISSE CUTS AMEC PRICE TARGET TO 1070 (1150) PENCE
----------
CREDIT SUISSE CUTS JOHN WOOD PRICE TARGET TO 790 (890) PENCE
----------
LIBERUM RAISES BELLWAY PRICE TARGET TO 1990 (1764) PENCE - 'BUY'
----------
EXANE BNP CUTS SYNTHOMER PRICE TARGET TO 205 (215) PENCE - 'NEUTRAL'
----------
HSBC CUTS SYNTHOMER PRICE TARGET TO 220 (230) PENCE - 'NEUTRAL'
----------
JEFFERIES CUTS SYNTHOMER PRICE TARGET TO 275 (314) PENCE - 'BUY'
----------
MAIN MARKET AND AIM
----------
BARCLAYS RAISES VECTURA GROUP PRICE TARGET TO 175 (171) PENCE - 'OVERWEIGHT'
----------
JEFFERIES CUTS IMAGINATION TECHNOLOGIES PRICE TARGET TO 242 (300) PENCE - 'BUY'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
27 May 2020 13:10

UK TRADING UPDATE SUMMARY: Caffyns To Reopen Showrooms As Curbs Ease

UK TRADING UPDATE SUMMARY: Caffyns To Reopen Showrooms As Curbs Ease

Read more
1 May 2020 14:30

Vectura upbeat on EMA nod for 'Enerzair Breezhaler'

(Sharecast News) - Inhalation contract manufacturer Vectura Group noted an announcement from Novartis on Friday, that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of 'Enerzair Breezhaler'.

Read more
23 Mar 2020 09:43

UK BROKER RATINGS SUMMARY: Barclays Raises Pearson, Moneysupermarket

UK BROKER RATINGS SUMMARY: Barclays Raises Pearson, Moneysupermarket

Read more
17 Mar 2020 12:31

Vectura Resilient Against Covid-19 As Flutiform Drives Annual Growth

Vectura Resilient Against Covid-19 As Flutiform Drives Annual Growth

Read more
10 Mar 2020 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
27 Jan 2020 09:36

UK BROKER RATINGS SUMMARY: Peel Hunt Cuts Ashtead And Raises DCC

UK BROKER RATINGS SUMMARY: Peel Hunt Cuts Ashtead And Raises DCC

Read more
21 Jan 2020 12:48

Avacta Group Hires Vectura Group CFO Fry As Non-Executive Director

Avacta Group Hires Vectura Group CFO Fry As Non-Executive Director

Read more
13 Jan 2020 09:19

Vectura Targeting New Royalties In 2020 As Glaxo Lawsuit Rumbles On

Vectura Targeting New Royalties In 2020 As Glaxo Lawsuit Rumbles On

Read more
13 Jan 2020 08:25

Vectura sees FY revenues and earnings 'at least' in line with expectations

(Sharecast News) - Pharmaceuticals company Vectura said on Monday that its base business had continued to perform well in 2019.

Read more
27 Nov 2019 08:26

TOP NEWS: Hikma Submits Response To Advair Application Deficiencies

TOP NEWS: Hikma Submits Response To Advair Application Deficiencies

Read more
29 Oct 2019 09:41

Vectura Group Hires Former GE Healthcare Exec Will Downie As New CEO

Vectura Group Hires Former GE Healthcare Exec Will Downie As New CEO

Read more
18 Oct 2019 16:06

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
4 Oct 2019 17:31

UPDATE 1-Vectura, Sandoz win ruling on inhaler packaging case against GSK

(Adds comment from GSK spokesman)Oct 4 (Reuters) - Vectura Group said on Friday a British court had ruled in its favour on the packaging of a generic version of an inhaler made by bigger rival GlaxoSmithKline.Vectura said the court dismissed all G...

Read more
4 Oct 2019 14:24

High Court Dismisses Glaxo Case Against Generic Seretide Accuhaler

High Court Dismisses Glaxo Case Against Generic Seretide Accuhaler

Read more
3 Oct 2019 16:04

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.